CANCER BOARD of the BREAST Vol.3 No.2(2017/メディカルレビュ-社(大型本) Patritumab deruxtecan in HER2-negative breast cancer: part Bの詳細情報
Patritumab deruxtecan in HER2-negative breast cancer: part B。A human breast cancer-derived xenograft and organoid。Novel Breast Cancer Brain Metastasis Patient-Derived。